Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.26 | N/A |
| PEG Ratio (TTM) | -0.50 | N/A |
| P/S Ratio (TTM) | 2.91 | N/A |
| P/B Ratio (TTM) | 0.92 | N/A |
| P/FCF Ratio (TTM) | 57.27 | N/A |
| Price to 5YR AVG Earnings Ratio | 0.02 | N/A |
| Price to 5YR AVG FCF Ratio | 0.01 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.29% | N/A |
| ROE (TTM) | 7.83% | N/A |
| Net Profit Margin (TTM) | 23.75% | N/A |
| ROIC 5YR AVG | -4.95% | N/A |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 134.47% | 127.43% | 81.85% |
| Revenue | 34.77% | 3.30% | 5.02% |
| Net Income | 158.40% | 127.38% | 81.82% |
| Cash Flow | -23.90% | 291.75% | 175.37% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 2.12 | N/A |
| Interest Coverage (TTM) | -0.44 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.43 | N/A |
| LTL to 5YR AVG FCF | 2.72 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.01% | N/A |